Texas 2009 - 81st Regular

Texas Senate Bill SB1092 Latest Draft

Bill / Introduced Version Filed 02/01/2025

Download
.pdf .doc .html
                            81R9501 ALB-D
 By: West S.B. No. 1092


 A BILL TO BE ENTITLED
 AN ACT
 relating to the screening of newborns for sickle-cell trait and
 other disorders by the Department of State Health Services.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1. The heading to Chapter 33, Health and Safety
 Code, is amended to read as follows:
 CHAPTER 33. PHENYLKETONURIA, OTHER HERITABLE DISEASES,
 HYPOTHYROIDISM, AND CERTAIN OTHER DISORDERS OR TRAITS
 SECTION 2. Sections 33.002(a) and (c), Health and Safety
 Code, are amended to read as follows:
 (a) The department shall carry out a program to combat
 morbidity, including mental retardation, and mortality in persons
 who have phenylketonuria, other heritable diseases, other
 disorders for which screening is required by the department,
 sickle-cell trait, or hypothyroidism.
 (c) The department shall establish and maintain a
 laboratory to:
 (1) conduct experiments, projects, and other
 activities necessary to develop screening or diagnostic tests for
 the early detection of phenylketonuria, other heritable diseases,
 other disorders for which screening is required by the department,
 sickle-cell trait, and hypothyroidism;
 (2) develop ways and means or discover methods to be
 used to prevent or treat phenylketonuria, other heritable diseases,
 other disorders for which screening is required by the department,
 sickle-cell trait, and hypothyroidism; and
 (3) serve other purposes considered necessary by the
 department to carry out the program.
 SECTION 3. Section 33.011(a), Health and Safety Code, is
 amended to read as follows:
 (a) The physician attending a newborn child or the person
 attending the delivery of a newborn child that is not attended by a
 physician shall subject the child to screening tests approved by
 the department for phenylketonuria, other heritable diseases,
 hypothyroidism, sickle-cell trait, and other disorders for which
 screening is required by the department.
 SECTION 4. Section 33.014(a), Health and Safety Code, is
 amended to read as follows:
 (a) If, because of an analysis of a specimen submitted under
 Section 33.011, the department reasonably suspects that a newborn
 child may have phenylketonuria, another heritable disease,
 hypothyroidism, sickle-cell trait, or another disorder for which
 the screening tests are required, the department shall notify the
 person who submits the specimen that the results are abnormal and
 provide the test results to that person. The department may notify
 one or more of the following that the results of the analysis are
 abnormal and recommend further testing when necessary:
 (1) the physician attending the newborn child or the
 physician's designee;
 (2) the person attending the delivery of the newborn
 child that was not attended by a physician;
 (3) the parents of the newborn child;
 (4) the health authority of the jurisdiction in which
 the newborn child was born or in which the child resides, if known;
 or
 (5) physicians who are cooperating pediatric
 specialists for the program.
 SECTION 5. Section 33.031(a), Health and Safety Code, is
 amended to read as follows:
 (a) All newborn children and other individuals under 21
 years of age who have been screened, have been found to be
 presumptively positive through the newborn screening program for
 phenylketonuria, other heritable diseases, hypothyroidism,
 sickle-cell trait, or another disorder for which the screening
 tests are required, and may be financially eligible may be referred
 to the department's services program for children with special
 health care needs.
 SECTION 6. Section 33.032(a), Health and Safety Code, is
 amended to read as follows:
 (a) Within the limits of funds available for this purpose
 and in cooperation with the individual's physician, the department
 may provide services directly or through approved providers to
 individuals of any age who meet the eligibility criteria specified
 by board rules on the confirmation of a positive test for
 phenylketonuria, other heritable diseases, hypothyroidism,
 sickle-cell trait, or another disorder for which the screening
 tests are required.
 SECTION 7. As soon as practicable after the effective date
 of this Act, the Department of State Health Services shall
 implement the changes in law made by this Act to the newborn
 screening program under Chapter 33, Health and Safety Code.
 SECTION 8. This Act takes effect September 1, 2009.